A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Radiotherapy is a major part in the treatment of most common cancers, but many patients experience local recurrence with metastatic disease. In evaluating response biomarkers, we found that low doses of fractionated radiotherapy led to PD-L1 upregulation on tumor cells in a variety of syngeneic mouse models of cancer. Notably, fractionated radiotherapy delivered in combination with aPD-1 or aPD-L1 mAbs generated efficacious CD8 þ T-cell responses that improved local tumor control, long-termdoi:10.1158/0008-5472.can-14-1258 pmid:25274032 fatcat:duueqqy3hfgczhkeucz7dmlumi